A case of intravascular bronchiolo-alveolar tumor, a rare lung neoplasm which is often found among women,is reported. Our ultrastructural findings and existence of factor VHI-related antigen support the hypothesis of vascular origin. The relationship between IVBATand epithelioid hemangioendothelioma is discussed.
In 1975, Dail and Liebow firstly reported twenty cases of a previously undescribed peculiar lung tumor as intravascular bronchiolo-alveolar tumor (IVBAT) . Since their abstract, some cases have been described2"ll.
The histogenesis of this tumor has not been clearly settled, but recent electron microscopic studies by Corrin etal. and Weldon-Linne et al.
have suggested that these tumors could originate from the endothelium of pulmonary vasculature.
We report a characteristic case of this rare tumor with some immunological data and discuss the relationship between "IVBAT" and "Epithelioid hemangioendothelioma"12^C
ASE REPORT
In 1983, a 40-year-old Japanese woman, a house wife, underwent a routine lung screening test and was found to have an abnormal shadow on her chest roentgenogram.
In July 1983, she was admitted to Tokyo University Hospital with no symptoms for evaluation. She had no special past, family, smoking and occupational histories.
Her chest roentgenogram showed multiple (about 80 in number) small nodules uniformly distributed throughout both lung fields ( Figure  1 ). These nodules ranged from 0. beyond five or ten years1. In Dail and Liebow's series, ten of twenty died and most of them were due to respiratory insufficiency subsequent to wide extension of the tumor. In the present case, liver lesion was not recognized in spite of serial examination, but our two other unpublished cases had liver lesions, and died of hepatic failure. Unlike highly malignant angiosarcoma, this endothelial tumor shows very insidious growth and can kill the sufferer in a time to come. Some therapeutic measures should be undertaken in an attempt to curb the progress of the disease. Considering its high propensity for women,antiestrogen drug such as tamoxiffen can be a candidate as a chemotherapeutic agent, if estrogen receptor exist on the tumor cells.
